Adagene Inc. revenue breakdown overview

Adagene Inc. revenue for the last year amounted to 18.11 M USD, the most of which — 18.11 M USD — came from its highest performing source at the moment, Monoclonal Antibody Drugs, the year earlier bringing 9.29 M USD. The greatest contribution to the revenue figure was made by China — last year it brought Adagene Inc. 18.11 M USD, and the year before that — 9.29 M USD.